本页面由Tiger Trade Technology Pte. Ltd.提供服务

Bicara Therapeutics

23.90
-0.4900-2.01%
盘后23.900.00000.00%19:30 EDT
成交量:49.64万
成交额:1,202.92万
市值:15.82亿
市盈率:-7.69
高:25.56
开:24.73
低:23.77
收:24.39
52周最高:30.99
52周最低:10.30
股本:6,617.29万
流通股本:5,230.21万
量比:1.00
换手率:0.95%
股息:- -
股息率:- -
每股收益(TTM):-3.1097
每股收益(LYR):-2.5230
净资产收益率:-41.01%
总资产收益率:-26.14%
市净率:3.37
市盈率(LYR):-9.47

数据加载中...

2026/08/14

超过5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/08/11

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/08/11

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2026/08/11

重要事件披露

Form 8-K - Current report
2026/08/10

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/08/10

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/08/10

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/07/28

重要事件披露

Form 8-K - Current report
2026/07/28

超过5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/07/10

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/07/08

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/07/08

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/07/08

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/07/07

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/06/25

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/06/10

重要事件披露

Form 8-K - Current report
2026/06/02

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/05/26

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/05/22

重要事件披露

Form 8-K - Current report
2026/05/21

关联方拟减持公告

Form 144 - Report of proposed sale of securities